Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
T Cells
100%
Genetic Modification
100%
Tumor-specific
100%
Antigen Presentation
100%
Cytotoxic T Lymphocytes
100%
Interleukin-21 (IL-21)
100%
Central Memory
100%
Antigen-specific
37%
Antigen-presenting Cells
37%
MART-1
37%
CD8+ T Cells
25%
Tumor Antigen
25%
Memory Phenotype
25%
Immune Response
12%
Adoptive Cell Therapy
12%
Cancer Treatment
12%
Healthy Individuals
12%
Cytotoxicity
12%
CD28
12%
CD62L
12%
Interferon-α (IFN-α)
12%
Cluster of Differentiation 44 (CD44)
12%
Human Leukocyte Antigen
12%
Non-transgenic
12%
Tumor Immunotherapy
12%
Antigenic Peptide
12%
Major Histocompatibility Complex
12%
Cytotoxic T Cell Response
12%
Cell-based Vaccine
12%
Primary Tumor Cells
12%
RHAMM
12%
Gene-modified
12%
Peptide Antigen
12%
T Antigen
12%
Interleukin-7 Receptor
12%
Terminal Effector
12%
Gp100
12%
CD45RA
12%
Melanoma Antigens
12%
CD27
12%
21-gene
12%
Synergize
12%
B-CLL
12%
Tumor Antigen-specific T Cell
12%
Immunology and Microbiology
Cytotoxic T Cell
100%
DNA Modification
100%
T Cell
100%
Antigen Presentation
100%
Interleukin 21
100%
Antigen-Presenting Cell
37%
Antigen Specificity
37%
Tumor Antigen
37%
Cytotoxic T-Cell
25%
Peptides
25%
Interferon Type I
12%
B Cell
12%
Interleukin-7 Receptor
12%
Immune Response
12%
Normal Human
12%
Cytotoxicity
12%
CD28
12%
Tumor Cell
12%
Major Histocompatibility Complex
12%
CD44
12%
Human Leukocyte Antigen
12%
Melanocyte Protein Pmel 17
12%
Cytokine
12%
Cancer Immunotherapy
12%